About us

Experts

News

Koru Academy

Technology

Contacts

Subscribe for news and promotions

About Contacts Brands Our Products

468, Bongeunsa-ro, Gangnam-gu, Seoul, Republic of Korea

info@korupharma.com

+82 70 4651 5197

Terms and Conditions Privacy Policy

All Rights Reserved 2025 © KORU Pharma Co., LTD.

Back

Sharper, Stronger, Defined: The Art of Male Facial Contouring

Sharper, Stronger, Defined: The Art of Male Facial Contouring

Dr Vincent Wong presenting the Art of Male Facial Contouring

Join us for an exclusive educational webinar with Dr. Vincent Wong, a renowned Aesthetic Doctor and Koru Pharma Key Opinion Leader, as we explore the evolving art and science of facial masculinisation using AVALON™ Fillers.

Learn how to create sharper, stronger, and more defined male features while maintaining natural facial harmony.

What You’ll Learn

Core principles of masculine contouring: projection, proportion, and structure
Strategic filler placement for jawline, chin, and midface enhancement
Expert insights into achieving natural yet powerful results

Speaker

Dr. Vincent Wong
Aesthetic Doctor | Koru Pharma KOL
International Speaker | Multi-Award-Winning Expert in Facial Aesthetics

📅 Date: 27 October 2025
⏰ Time: 8:00 PM (GMT +1)
💎 Featured Product: AVALON™ Fillers
🌐 Language: English

Limited seats available – early registration is highly recommended.

Register Now to secure your spot: https://zoom.us/webinar/register/8917591357077/WN_3vn6J8p4Qkiw06AOPId3yg

More News

Avalon Fine and Vital Awarded CE MDR Mark, with Additional Certifications Underway Koru Pharma has confirmed that Avalon Fine and Avalon Vital, have been awarded the CE MDR mark, signifying full compliance with the European Union’s Medical Device Regulation (MDR 2017/745). The certification authorises these products to be marketed and distributed throughout the European Economic Area (EEA).

From International Student to CEO - The Journey of a Young Russian Entrepreneur in KoreaStrong Q3 results, East Asia expansion, and upcoming IPO plans—discover the key highlights from Koru Pharma’s latest feature in Aju Business Daily.

MESOHEAL® Phlo Launch : Skin Boosters with Dual HA and PolynucleotideOct 07, 2025 - Koru Pharma today announced the launch of MESOHEAL® Phlo, a groundbreaking skin booster that merges high-potency hyaluronic acid (HA) with polynucleotides (PN) in an advanced thermal bonding formulation.

Avalon Fine and Vital Awarded CE MDR Mark, with Additional Certifications Underway Koru Pharma has confirmed that Avalon Fine and Avalon Vital, have been awarded the CE MDR mark, signifying full compliance with the European Union’s Medical Device Regulation (MDR 2017/745). The certification authorises these products to be marketed and distributed throughout the European Economic Area (EEA).

From International Student to CEO - The Journey of a Young Russian Entrepreneur in KoreaStrong Q3 results, East Asia expansion, and upcoming IPO plans—discover the key highlights from Koru Pharma’s latest feature in Aju Business Daily.

MESOHEAL® Phlo Launch : Skin Boosters with Dual HA and PolynucleotideOct 07, 2025 - Koru Pharma today announced the launch of MESOHEAL® Phlo, a groundbreaking skin booster that merges high-potency hyaluronic acid (HA) with polynucleotides (PN) in an advanced thermal bonding formulation.

Koru Pharma Achieves Major Milestone with EUIPO Trademark Registration for AVALON BrandLeading aesthetics company strengthens European market position with official trademark protection. Koru Pharma has reached a significant milestone in its European expansion with the successful registration of its AVALON brand trademark through the European Union Intellectual Property Office (EUIPO).

Business Insider features Koru Pharma CEO Roman Vernidub on building in Korea as a foreign entrepreneurBusiness Insider has featured Koru Pharma CEO Roman Vernidub in a profile on his journey as a foreign entrepreneur in Korea. The profile traces his path from student to founder and examines how cultural understanding and disciplined execution shape the way he works.

Reversal Dual Launch: A Breakthrough Dual-Vial Skin BoosterKoru Pharma proudly introduces Reversal Dual, an advanced mesotherapy innovation that combines Poly-L-Lactic Acid (PLLA) and Hyaluronic Acid (HA) in a single treatment. Expanding the Reversal brand family, Reversal Dual brings together hydration and biostimulation in one synergistic solution for comprehensive skin rejuvenation.

Pink Glow Clinical Efficacy Proven in Journal of Dermatology Research PublicationAugust 20, 2025 – A newly published case study of experts Dr. Vincent Wong and Dr. Abdulrahman Abdulbaky in the Journal of Dermatology Research has confirmed the clinical efficacy and safety of Pink Glow®, a glutathione-based mesotherapy solution, in the treatment of hyperpigmentation for darker skin types.

Reversal Neo Launch: The Next Generation of Collagen BiostimulationJuly 29, 2025 – Koru Pharma is proud to announce the official launch of Reversal Neo, a next-generation collagen-stimulating injectable designed to meet the evolving needs of aesthetic professionals and their patients seeking long-lasting, natural-looking rejuvenation.

Koru Pharma Achieves MDSAP Certification, Reinforcing Global Quality StandardsJuly 28, 2025, Koru Pharma is proud to announce a significant milestone in its commitment to safety, quality, and regulatory compliance. Following a comprehensive official audit, we have successfully obtained Medical Device Single Audit Program (MDSAP) certification

Koru Academy Officially Launches: A Global Platform for Aesthetic EducationJuly 24, 2025, Where can aesthetic professionals gain access to trusted clinical knowledge and hands-on expertise? Koru Pharma is answering that question with the launch of Koru Academy

Get the Glow: Modern mesotherapy for radiant skinJuly 16, 2025 - Koru Pharma's exclusive webinar titled “Get the Glow: modern mesotherapy for radiant skin,” featuring internationally recognised aesthetic expert Dr. Vincent Wong.The event introduced

Renoxome+ Launch: A New Skin Booster for Deep HealingJuly 10, 2025 - Koru Pharma proudly announces the global launch of Renoxome+, a powerful new addition to its advanced aesthetic product portfolio.

The Science Behind MESOHEAL® Bio: A New Era in Skin RejuvenationJuly 10th, 2025 - Koru Pharma, a leading global aesthetics company, successfully hosted an educational webinar “The Science Behind MESOHEAL® Bio: A New Era in Skin Rejuvenation”

Koru Pharma Showcases AVALON™ Expertise at IMCAS Asia 2025 SymposiumJune 8, 2025 - At the heart of IMCAS Asia 2025, Koru Pharma proudly presented a dynamic one-hour symposium “Dermal Filler Injection Essentials: Face Types, Complications & Customised Experience”

KORU GALA Asia 2025: A Night of Innovation, Recognition, and Celebration in BangkokJune 7, 2025 — Against the dazzling backdrop of Bangkok’s skyline, the KORU GALA 2025 unfolded in spectacular fashion at the iconic Penthouse Bar & Grill, Park Hyatt Bangkok.

Koru Academy Workshop at IMCAS Asia 2025June 7, 2025 - Achieving a Naturally Glowing Complexion with Mesoheal® Pink Glow - As part of Koru Pharma’s commitment to education and innovation, the Koru Academy proudly hosted an Innovative Industry Lecture at IMCAS Asia 2025, focused on skin revitalisation using Mesoheal® Pink Glow.

Koru Pharma at IMCAS Asia 2025, BangkokJune 6–8, 2025 | Bangkok, Thailand – Koru Pharma proudly participated in IMCAS Asia 2025, held at The Athenee Hotel, a Luxury Collection Hotel. The event brought together leading professionals in aesthetic medicine, dermatology, and plastic surgery

Koru Pharma Recognised by Inc. Magazine as a Global Leader in Aesthetic Biotech!30 May 2025 - We’re thrilled to share some exciting news! Koru Pharma has been featured in Inc. magazine in a powerful new article spotlighting South Korea’s booming aesthetic tech scene!

Protecting Our Clients from Counterfeit MESOHEAL® Pink GlowMay 8 2025 - IMPORTANT Announcement! Counterfeit versions of Mesoheal® Pink Glow circulating in the market. These unauthorised imitations not only compromise the integrity of our brand but also pose serious risks to client safety.

Mesoheal® Bio Has Arrived: The Future of Hydration and Firmness is HereApril 22, 2025 - Koru Pharma proudly introduces Mesoheal® Bio, the latest innovation in skin rejuvenation technology. ACAPLEX™ and 1.5% dual molecular Hyaluronic Acid (HA)

Dr Paola Rojas Leads Koru Pharma Webinar on Glow Line InnovationsApril 23 2025 - Koru Pharma hosted a highly successful live webinar on April 21, 2025, featuring renowned aesthetics expert Dr. Paola Rojas Saavedra. Titled "Team Glow Decode: Beyond the Glow"

Regenerative Lifting by Dr. Paola at AMWCApril 4 2025 - Koru Pharma is proud to announce that our Key Opinion Leader (KOL), Dr. Paola Rojas Saavedra, has been featured in the latest edition of AMWC’s Aesthetic Guide with her pioneering article:

Koru Pharma at Dubai Derma 2025 21 March 2025 - We are excited to announce that Koru Pharma will be exhibiting at Dubai Derma 2025, the leading event for dermatology, aesthetic medicine, and skincare!

Asia Economy: Koru Pharma Patents Next-Gen BDDE-Free FillerMarch 17, 2025 — Koru Pharma, a global leader in medical aesthetics, has secured a patent for its next-generation hyaluronic acid-agarose filler technology, a breakthrough

AMWC Monaco 2025 & Exclusive SymposiumMarch 27-29, 2025 – Grimaldi Forum, Monte Carlo, Monaco, Koru Pharma is excited to announce its participation in AMWC Monaco 2025

RenoXome Webinar by Dr. Oscar Suárez February 26, 2025 – Koru Pharma has successfully hosted an exclusive webinar featuring Dr. Oscar Suárez, a distinguished expert in aesthetic medicine.

Koru Pharma’s Special Webinar with Dr. Carlos MuñozJanuary 28, 2025 – Koru Pharma successfully hosted an exclusive webinar featuring Dr. Carlos Muñoz, a distinguished medical surgeon and international speaker.

IMCAS World Congress 2025 in ParisParis, France – February 1, 2025 – Koru Pharma successfully concluded its participation at the IMCAS World Congress 2025, held at Palais des Congrès in Paris from January 30 to February 1, 2025. As one of the leading global events in

Crystal healer PN Webinar by Dr Zoya EvsyukovaMoscow, Russia – December 12, 2024 – Koru Academy successfully hosted an insightful webinar on Crystal Healer PN, featuring renowned expert Dr. Zoya Evsyukova. The event, conducted in Russian, provided an in-depth discussion on

Koru Pharma presents advanced solutions for rejuvenationKoru Pharma, a pioneer in anti-aging and rejuvenation, proudly introduces its newest products: Crystal Healer PN and Crystal Healer PN+.

Koru Pharma Recognised by CHOSUN DAILY Koru Pharma, a leading exporter of medical and beauty products, has been featured in Joseon Ilbo

Koru Pharma New HeadquartersKoru Pharma Co., Ltd. has expanded its headquarters office to the 16th floor of a newly built high-rise in Seoul’s bustling Gangnam district.

Koru Pharma Launches AVALON Clinical Trials in ChinaKoru Pharma is taking a significant step forward in solidifying its presence in Asia’s largest market by initiating clinical trials for our cross-linked hyaluronic acid filler, “AVALON ,” in China.

Breakthrough Patent for Next-Generation Filler TechnologyKoru Pharma has secured a patent for its next-generation filler technology, eliminating the need for chemical cross-linking agents. This milestone advances our commitment to safer, more effective aesthetic solutions.

Celebrating Innovation at the 2024 Koru Pharma Gala NightOn June 22nd 2024, Koru Pharma warmly welcomed our esteemed clients and partners to a magical evening of music, cocktails, and hors d’oeuvres at the Gala Night 2024, held at the luxurious penthouse bar in Bangkok, Thailand.

Koru Pharma’s H Bloom obtains CE certificationKoru Pharma’s trademark product H Bloom is now CE approved.

Koru Pharma in the spotlight of Chosun IlboHighlighted by a leading Korean newspaper, Koru Pharma is redefining the beauty industry by exporting premium aesthetic products to over 100 countries. Discover the story behind our founder’s vision and commitment to innovation.

I Want The Beauty Industry To Associate "MADE IN KOREA" With Koru PharmaRoman Vernidub, the CEO of Koru Pharma, plans to expand the manufacturing capacity of the company’s factory to 3 million syringes by the end of 2025 and reach a revenue of 70 billion won.

Benzinga features Mesohemp as a Professional Cosmetic LineBenzinga recently published an article about our new cosmetic line; Mesohemp.

Mesoheal® Glow Series launchThe Mesoheal® Glow Series represents a significant advancement in skincare technology, leveraging the latest scientific research and cutting-edge ingredients to deliver exceptional results.

Koru Pharma CEO Roman Vernidub Shares Insights on Doing Business in East Asia in TNW FeatureRoman Vernidub, the CEO of Koru Pharma, was featured in a story by The Next Web (TNW). The article delves into the unique challenges and opportunities for startups and businesses entering the East Asian market. As a leader in the pharmaceutical and aesthetic medicine industries, Roman brought valuable insights and practical strategies to the conversation.

Koru Pharma open manufacturing facility in KoreaOur new HA filler facility is comprised of a 1,800 square meter assembly area, along with designated product storage areas and a loading dock. Production capacity is 3 million syringes per annum.

Koru Pharma Launches New Brand: MesohempKoru Pharma has recognised the growing demand for hemp-based products in the market, and in response, the company has developed a new product line – Mesohemp. This marks...

Introducing Mesoheal® Shape 10mlKoru Pharma has expanded its Mesoheal® Body HA line with the introduction of the Mesoheal® Shape 10ml

Koru Pharma Enhances Mesoheal Body HA 50ml with Innovative AdaptorKoru Pharma is proud to announce an exciting improvement to its Mesoheal Body HA 50ml product. In response to valuable feedback from clients, we have introduced a simple yet innovative adaptor designed to make the extraction process smoother and more efficient.

Koru Pharma Opens New R&D Laboratory in Chucheon, South KoreaKoru Pharma is excited to announce the opening of our state-of-the-art R&D laboratory in Chucheon, South Korea, which is fully equipped to support our ongoing research and development efforts. This new facility marks a significant milestone in our commitment to innovation and the advancement of medical solutions.

Koru Pharma develop MCO® Tech.Koru Pharma's R&D Institute completed development of MCO® Tech. (Minimising Cross-linking agent by Optimising reaction Technology), a technology that is used when manufacturing our dermal fillers.

Koru Pharma at IMCAS Asia 2024Koru Pharma Shines at Asia’s Premier B2B Event for Dermatology, Plastic Surgery, and Aging Science in Bangkok

Expanding Global Reach with Latest Launches at IMCAS ASIA 2024Koru Pharma Expands Global Reach with Latest Launches at IMCAS ASIA 2024

Koru Pharma at IMCAS Americas 2024Koru Pharma recently participated in IMCAS Americas held in São Paulo, Brazil, where we showcased our innovative medical solutions to professionals worldwide.

Dubai Derma 2024 - H Bloom Workshop by Dr.Carlos MuñozKoru Pharma participated in the 23rd edition of Dubai Derma, providing attendees with a distinctive opportunity to broaden their understanding.

AMWC Monaco 2024 SymposiumsAt Koru Pharma, we specialize in innovative medical solutions for corrective and aesthetic applications, delivering lasting results. We work closely with healthcare professionals to understand their needs and those of their patients.

Koru Pharma at AMWC Monaco 2024Koru Pharma had a successful experience at the industry’s leading event, dedicated to advancing physician education and cultivating valuable new professional relationships.

Koru Pharma at CIBE Guangzhou 2024Koru Pharma recently participated in CIBE Guangzhou 2024, which stands as China’s leading beauty industry platform. This prestigious aesthetic event provided us with the opportunity to engage with both our established partners and new industry experts.

Koru Pharma at Dubai Derma 2024Our first appearance at the Beauty Expo in Sydney, Australia, was a fantastic opportunity to introduce our innovative product range...

Koru Pharma Honored with President's Award for Outstanding Contribution to Export ExcellenceIn recognition of excellence in international trade, Koru Pharma has been bestowed with the prestigious President’s Award for achieving an outstanding export milestone of 10 million USD.

‎ TERMS AND CONDITIONS‎

PRIVACY POLICY‎

Koru Pharma’s AVALON™ Fillers obtain Certification in the Russian FederationKoru Pharma’s premium hyaluronic acid fillers AVALON™ have recently been granted product approval by the Federal Service for Surveillance in Healthcare of Russian Federation.

Products

AVALON™ Fillers

Avalon™ Fillers — non-animal origin stabilised hyaluronic acid fillers for correction of wrinkles and lines of different depths, restoration of volume loss, lip augmentation, and correction of the face contours.

AVALON™ Fillers

MESOHEAL® Glow Series

Mesoheal® Glow Series by Koru Pharma, formulated for skin rejuvenation and radiance. These professional-grade products provide deep hydration and restore skin vitality, perfect for clinics and beauty professionals.

MESOHEAL® Glow Series

Crystal Healer PN Series

Ultimate skin regeneration and elasticity boost. Revitalise damaged skin and achieve a youthful appearance with our advanced skincare solution.

Crystal Healer PN Series